Management of neurodegenerative disorders.
A symposium on 'Neurodegenerative disorders: from management to disease modification', organized by Athena Neurosciences (a division of Elan Pharma Ltd) was held at the Royal College of Physicians in London. Speakers outlined recent clinical advances in understanding of the underlying mechanisms of conditions such as multiple sclerosis, Alzheimer's disease and Parkinson's disease.